Short sellers made bold new bets this week — while retreating just as fast elsewhere.
Replimune saw the sharpest SI jump among large caps. Its SI % of Free Float hit 37.8%, up 10.4 percentage points in just seven days. Bears are clearly nervous about the oncology biotech's next catalyst.
Wolfspeed remains the most crowded short among mid-cap names. SI stands at 85.2% of FF, up another 6.9pp this week. Zero shares are available to borrow. That combination — extreme shorts with no availability — makes a squeeze mathematically plausible.
The week's biggest unwind happened in SpaceX. Short interest collapsed 14.5pp to 22% of FF as Harvard's $2.2bn stake grabbed headlines and bullish sentiment surged. Shorts fled.
Chewy also saw a sharp cover — SI fell 12.3pp to 66.4% of FF. Availability sits at 466%, meaning borrow is plentiful. That cushion limits squeeze risk despite the still-elevated reading.
Campbell's is a quieter mover worth watching. SI climbed nearly 4pp to 25.1% as the food giant faces margin pressure. Bears are betting the defensive trade turns offensive.
Galectin Therapeutics holds the highest short score at 90, with 68.9% of FF shorted and availability near 12%. That is a powder keg.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
